Aldosterone News and Research

RSS

Aldosterone is a steroid hormone made by the adrenal cortex (the outer layer of the adrenal gland). It helps control the balance of water and salts in the kidney by keeping sodium in and releasing potassium from the body. Too much aldosterone can cause high blood pressure and a build-up of fluid in body tissues. Aldosterone is a type of mineralocorticoid hormone.

How the gut microbiome could affect COVID-19 severity

Researchers review the potential role of the gut microbiome in determining severe COVID-19.

27 Sep 2022

Association of self-reported chronic fatigue and retinal microcirculation in post-COVID-19 syndrome patients

Researchers investigated the potential association between self-reported chronic fatigue and retinal microcirculation among post-COVID-19 syndrome patients.

27 Sep 2022

How does SARS-CoV-2 infection impact fertility in men?

In a recent review published in the journal Endocrines, researchers summarized existing literature findings on the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on the male reproductive system and fertility.

7 Sep 2022

The possible association between SARS-CoV-2, ACE2, TMPRSS2, and skin manifestations

A new study analyzed the possibility of penetration of SARS-CoV-2 into the skin.

5 Sep 2022

Combination of anemia and weak muscles increases the risk of death in older people

A study by researchers at the Federal University of São Carlos in Brazil and University College London in the United Kingdom shows that a combination of anemia and weak muscles in older people heightens the risk of death in ten years by 64% for men and by 117% for women.

29 Aug 2022

Aldosterone may increase risk of kidney failure in patients with chronic kidney disease

A steroid hormone called aldosterone is linked to an increased risk of kidney failure in patients with chronic kidney disease (CKD), according to a study published in the European Heart Journal today (Tuesday).

8 Aug 2022

New noninvasive method could allow screening for hypertension-linked aldosterone adenomas

Researchers have developed a noninvasive method to identify a potential cause of hypertension with a drastic reduction in radiation exposure, a study shows.

13 Jul 2022

Bereavement linked to increased risk of death in heart failure patients

Heart failure patients experiencing grief or in mourning following the loss of a close family member are at an increased risk of death, particularly during the first week following the family member's death, according to a study published today in JACC: Heart Failure.

6 Jul 2022

Midgestation increase in leptin puts child and mother at risk of cardiovascular disease

Before a baby is ever born, critical supply chain problems with nutrition and oxygen can result in premature birth or even death and increase the child and mother's lifelong risk of cardiovascular disease.

23 Jun 2022

Use of RAAS inhibitors reduced aneurysm rupture risk by 18%, finds study

A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications, reduced the risk of an aneurysm rupture by 18%, according to new research published today in Hypertension, a peer-reviewed journal of the American Heart Association.

3 Jun 2022

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

A recent study posted to the medRxiv* preprint server investigated the association of renin-angiotensin-aldosterone system (RAAS)-mediated hypertension (HT) with coronavirus disease 2019 (COVID-19).

6 Apr 2022

Patiromer lowers hyperkalemia risk in heart failure patients taking RAASi therapy

Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing too much potassium—compared with a placebo, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Aldosterone News and Research

How the gut microbiome could affect COVID-19 severity

Association of self-reported chronic fatigue and retinal microcirculation in post-COVID-19 syndrome patients

How does SARS-CoV-2 infection impact fertility in men?

The possible association between SARS-CoV-2, ACE2, TMPRSS2, and skin manifestations

Combination of anemia and weak muscles increases the risk of death in older people

Aldosterone may increase risk of kidney failure in patients with chronic kidney disease

New noninvasive method could allow screening for hypertension-linked aldosterone adenomas

Bereavement linked to increased risk of death in heart failure patients

Midgestation increase in leptin puts child and mother at risk of cardiovascular disease

Use of RAAS inhibitors reduced aneurysm rupture risk by 18%, finds study

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

Patiromer lowers hyperkalemia risk in heart failure patients taking RAASi therapy

Mineralocorticoid receptor antagonist use linked to improved renal prognosis in CKD patients

Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes

Aldosterone levels undetectably low in hospitalized COVID-19 patients

Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

Study finds SARS-CoV-2 infection caused significant changes in the levels of stress associated small RNAs

Impact of SARS-CoV-2 infection on testis function

Aspirin use associated with raised risk of heart failure

Current understanding of the link between COVID-19 and cardiovascular disease

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News